Search Results - "Mera Carreiro, Sara"

Impact of Treatment with GLP1 Receptor Agonists, Liraglutide 3.0 mg and Semaglutide 1.0 mg, While on a Waiting List for Bariatric Surgery by Rubio-Herrera, Miguel A, Mera-Carreiro, Sara, Sánchez-Pernaute, Andrés, Ramos-Levi, Ana M

“…Background: Weight loss before undergoing metabolic and bariatric surgery (MBS) has been suggested to reduce perioperative complications, although with…”
Get full text

Chronic Treatment with Somatostatin Analogues in Recurrent Type 1 Gastric Neuroendocrine Tumors by Sebastian-Valles, Fernando, Bernaldo Madrid, Blanca, Sager, Carolina, Carrillo López, Elena, Mera Carreiro, Sara, Ávila Antón, Laura, García, Noelia Sánchez-Maroto, Sampedro-Nuñez, Miguel Antonio, Díaz Pérez, Jose Ángel, Marazuela, Mónica

“…Type 1 gastric neuroendocrine tumors (GC-1) represent an uncommon subtype of neoplasms. Endoscopic resection has been proposed as the treatment of choice;…”
Get full text

Delayed Type Hypersensitivity Reaction Induced By Liraglutide With Tolerance to Semaglutide by Moreno-Borque, Ricardo, Guhl-Millán, Guillermo, Mera-Carreiro, Sara, Pazos-Guerra, Mario, Cortés-Toro, Jose Antonio, López-Bran, Eduardo

“…Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the management of type 2 diabetes and obesity. It was the first GLP-1 receptor…”
Get full text

CO026 - CONCORDANCIA ENTRE LA 18F-FLUOROCOLINA PET-TC Y LA CIRUGÍA EN LA LOCALIZACIÓN DE ADENOMAS DE PARATIROIDES EN PACIENTES CON HIPERPARATIROIDISMO PRIMARIO by Oñate, Paloma Daudén, Candil, Aída Ortega, Rey, Cristina Rodríguez, Domingo, Gonzalo Cuesta, Cámara, Santiago Ochagavía, Serrano, Inmaculada Domínguez, Carreiro, Sara Mera, Navas, Maglen Katherine Meneses, Martín, María Nieves Cabrera

Get full text